141 related articles for article (PubMed ID: 2874859)
1. Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
Belpaire FM; Bogaert MG; Mugabo P; Rosseel MT
Br J Pharmacol; 1986 Jul; 88(3):697-705. PubMed ID: 2874859
[TBL] [Abstract][Full Text] [Related]
2. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
[TBL] [Abstract][Full Text] [Related]
3. Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.
Lochan R; Silke B; Taylor SH
Br J Clin Pharmacol; 1981 Nov; 12(5):721-4. PubMed ID: 6120711
[TBL] [Abstract][Full Text] [Related]
4. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
Schneider RE; Bishop H; Kendall MJ; Quarterman CP
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
[TBL] [Abstract][Full Text] [Related]
5. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
6. Diazepam/beta-adrenoceptor antagonist interactions.
Hawksworth G; Betts T; Crowe A; Knight R; Nyemitei-Addo I; Parry K; Petrie JC; Raffle A; Parsons A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):69S-76S. PubMed ID: 6146341
[TBL] [Abstract][Full Text] [Related]
7. Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats.
Street JA; Hemsworth BA; Roach AG; Day MD
Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):180-90. PubMed ID: 39524
[TBL] [Abstract][Full Text] [Related]
8. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.
Belpaire FM; Bogaert MG; Rosseneu M
Eur J Clin Pharmacol; 1982; 22(3):253-6. PubMed ID: 6125395
[TBL] [Abstract][Full Text] [Related]
9. Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
Nakasone J; Kato T; Noguchi K; Nagamine F; Sakanashi M
Jpn J Pharmacol; 1988 Aug; 47(4):387-95. PubMed ID: 2903263
[TBL] [Abstract][Full Text] [Related]
10. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
[TBL] [Abstract][Full Text] [Related]
11. Binding of oxprenolol and propranolol to serum, albumin and alpha 1-acid glycoprotein in man and other species.
Belpaire FM; Braeckman RA; Bogaert MG
Biochem Pharmacol; 1984 Jul; 33(13):2065-9. PubMed ID: 6743355
[TBL] [Abstract][Full Text] [Related]
12. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
[No Abstract] [Full Text] [Related]
13. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
[TBL] [Abstract][Full Text] [Related]
15. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
16. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
Kaplan HR; Commarato MA
J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
[No Abstract] [Full Text] [Related]
17. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
[TBL] [Abstract][Full Text] [Related]
19. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
[TBL] [Abstract][Full Text] [Related]
20. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
